ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

PLRX Pliant Therapeutics Inc

13,79
-0,19 (-1,36%)
Após o horário de negociação
Última atualização: 17:03:43
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Pliant Therapeutics Inc PLRX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,19 -1,36% 13,79 17:03:43
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
14,09 13,71 14,33 13,76 13,98
mais cotações »

Notícias Recentes

Data Hora Fonte Título
06/05/202417:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
01/05/202409:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
02/04/202409:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
27/03/202411:23GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
12/03/202408:30GLOBEPliant Therapeutics Announces Accelerated Bexotegrast..
27/02/202418:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
26/02/202410:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
07/02/202410:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
04/02/202417:29GLOBEPliant Therapeutics Announces Positive Safety and..
03/01/202410:00GLOBEPliant Therapeutics to Participate in the 42nd Annual J.P...
13/11/202318:30GLOBEPliant Therapeutics Presentations at The Liver Meeting® 2023..
09/11/202318:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
08/11/202310:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
06/11/202310:00GLOBEPliant Therapeutics Presentations at the Annual Meeting of..
31/10/202317:03GLOBEPliant Therapeutics Announces Three Presentations at the..
19/10/202309:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data..
16/10/202317:05GLOBEPliant Therapeutics Appoints S. Mishima Gerhart as Chief..
26/09/202308:30GLOBEPliant Therapeutics Announces Positive Safety and..
25/09/202317:05GLOBEPliant Therapeutics to Host Investor Call and Webcast to..
15/09/202309:00GLOBEPliant Therapeutics Appoints Minnie Kuo as Chief Development..
11/09/202309:00GLOBEPliant Therapeutics Announces Presentations at the European..
30/08/202309:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
28/08/202317:05GLOBEPliant Therapeutics Announces Three Upcoming Presentations..
09/08/202317:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
09/08/202309:00GLOBEPliant Therapeutics Announces Initiation of BEACON-IPF, a..
25/07/202309:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
23/06/202308:30GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
24/05/202309:00GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
10/05/202309:05GLOBEPliant Therapeutics to Participate in Upcoming Investor..
09/05/202317:02GLOBEPliant Therapeutics Provides Corporate Update and Reports..

Seu Histórico Recente

Delayed Upgrade Clock